Cerevel Therapeutics Holdings, Inc.
CERENASDAQHealthcare
$44.96
+$0.33(+0.74%)
Market Cap$8.2B
P/E Ratio—
52W High$44.99
52W Low$19.59
Cerevel Therapeutics Holdings, Inc. (CERE) Stock Splits
No forward or reverse splits on record since IPO — details below.
FMP · CERE · as of Jul 31, 2024
Key split metrics
—
Cerevel Therapeutics Holdings, Inc. (CERE) has been publicly traded since Jul 30, 2020 with no forward or reverse splits on record.
About stock split history
Cerevel Therapeutics Holdings, Inc. (CERE) has never undergone a stock split since going public.
Frequently asked questions
Cerevel Therapeutics Holdings, Inc. (CERE) has never split its stock since going public.
CERE stock split historyhas CERE ever stock splitno stock split since IPO
Data: Financial Modeling Prep · Updated daily · For informational purposes only, not investment advice.